Moleculent
Signal active
Organization
Contact Information
Overview
Moleculent is on a mission to develop technology-enabled products that leverage new insights into the molecular foundation of human biology. Developing amazing products to advance human health gives you purpose. they believe that our understanding of the molecular basis of human biology, in health and disease will increase radically in the coming ten years. This will lead to a vast improvement in therapies, diagnostics, and a new, fundamental understanding
About
Industries
Biotechnology
Founded
Invalid date
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Moleculent headquartered in Europe, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $104.0M in funding across 4 round(s). With a team of 11-50 employees, Moleculent is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Moleculent, raised $26.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$26.0M
Details
1
Moleculent has raised a total of $26.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Early Stage Venture | 26.0M |
Investors
Moleculent is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| EIR Ventures | - | FUNDING ROUND - EIR Ventures | 26.0M |
| Sean Kendall | - | FUNDING ROUND - Sean Kendall | 26.0M |
| Moleculent | - | FUNDING ROUND - Moleculent | 26.0M |
| ARCH Venture Partners | - | FUNDING ROUND - ARCH Venture Partners | 26.0M |
Recent Activity
There is no recent news or activity for this profile.